Literature DB >> 16135919

Determinants of long-term survival after major surgery and the adverse effect of postoperative complications.

Shukri F Khuri1, William G Henderson, Ralph G DePalma, Cecilia Mosca, Nancy A Healey, Dharam J Kumbhani.   

Abstract

OBJECTIVE: The objective of this study was to identify the determinants of 30-day postoperative mortality and long-term survival after major surgery as exemplified by 8 common operations. SUMMARY BACKGROUND DATA: The National Surgical Quality Improvement Program (NSQIP) database contains pre-, intra-, and 30-day postoperative data, prospectively collected in a standardized fashion by a dedicated nurse reviewer, on major surgery in the Veterans Administration (VA). The Beneficiary Identification and Records Locator Subsystem (BIRLS) is a VA file that depicts the vital status of U.S. veterans with 87% to 95% accuracy.
METHODS: NSQIP data were merged with BIRLS to determine the vital status of 105,951 patients who underwent 8 types of operations performed between 1991 and 1999, providing an average follow up of 8 years. Logistic and Cox regression analyses were performed to identify the predictors of 30-day mortality and long-term survival, respectively.
RESULTS: The most important determinant of decreased postoperative survival was the occurrence, within 30 days postoperatively, of any one of 22 types of complications collected in the NSQIP. Independent of preoperative patient risk, the occurrence of a 30-day complication in the total patient group reduced median patient survival by 69%. The adverse effect of a complication on patient survival was also influenced by the operation type and was sustained even when patients who did not survive for 30 days were excluded from the analyses.
CONCLUSIONS: The occurrence of a 30-day postoperative complication is more important than preoperative patient risk and intraoperative factors in determining the survival after major surgery in the VA. Quality and process improvement in surgery should be directed toward the prevention of postoperative complications.

Entities:  

Mesh:

Year:  2005        PMID: 16135919      PMCID: PMC1357741          DOI: 10.1097/01.sla.0000179621.33268.83

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

1.  Using the Veterans Administration National Surgical Quality Improvement Program to improve patient outcomes.

Authors:  L Neumayer; M Mastin; L Vanderhoof; D Hinson
Journal:  J Surg Res       Date:  2000-01       Impact factor: 2.192

2.  Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries.

Authors:  G S Cooper; Z Yuan; C S Landefeld; A A Rimm
Journal:  Am J Public Health       Date:  1996-04       Impact factor: 9.308

3.  Risk factors for morbidity and mortality after colectomy for colon cancer.

Authors:  W E Longo; K S Virgo; F E Johnson; C A Oprian; A M Vernava; T P Wade; M A Phelan; W G Henderson; J Daley; S F Khuri
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

4.  Intraoperative regional myocardial acidosis and reduction in long-term survival after cardiac surgery.

Authors:  Shukri F Khuri; Nancy A Healey; Monir Hossain; Vladimir Birjiniuk; Michael D Crittenden; Miguel Josa; Patrick R Treanor; Samer F Najjar; Dharam J Kumbhani; William G Henderson
Journal:  J Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 5.209

5.  Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery.

Authors:  M D Kertai; E Boersma; J Klein; H Van Urk; J J Bax; D Poldermans
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-07       Impact factor: 7.069

6.  Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program.

Authors:  Kevin G Billingsley; Kwan Hur; William G Henderson; Jennifer Daley; Shukri F Khuri; Richard H Bell
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

Review 7.  Death associated with asymptomatic carotid artery stenosis: long-term clinical evaluation. VA Cooperative Study 167 Group.

Authors:  S N Cohen; R W Hobson; D G Weiss; M Chimowitz
Journal:  J Vasc Surg       Date:  1993-12       Impact factor: 4.268

8.  Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study.

Authors:  J Gibbs; W Cull; W Henderson; J Daley; K Hur; S F Khuri
Journal:  Arch Surg       Date:  1999-01

9.  Predictors of mortality in adult trauma patients: the physiologic trauma score is equivalent to the Trauma and Injury Severity Score.

Authors:  Deborah A Kuhls; Debra L Malone; Robert J McCarter; Lena M Napolitano
Journal:  J Am Coll Surg       Date:  2002-06       Impact factor: 6.113

10.  Operative mortality and long-term relative survival of patients operated on for asymptomatic abdominal aortic aneurysm.

Authors:  S Aune; S R Amundsen; J Evjensvold; A Trippestad
Journal:  Eur J Vasc Endovasc Surg       Date:  1995-04       Impact factor: 7.069

View more
  330 in total

1.  Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection.

Authors:  Wen-Sy Tsai; Pao-Shiu Hsieh; Chien-Yuh Yeh; Jy-Ming Chiang; Reiping Tang; Jinn-Shiun Chen; Chung Rong Changchien; Jeng Yi Wang
Journal:  Int J Clin Oncol       Date:  2012-01-20       Impact factor: 3.402

2.  Effect of surgical approach on 30-day mortality and morbidity after elective colectomy: a NSQIP study.

Authors:  Molly M Cone; Daniel O Herzig; Brian S Diggs; Jennifer D Rea; Karin M Hardiman; Kim C Lu
Journal:  J Gastrointest Surg       Date:  2012-03-09       Impact factor: 3.452

3.  Variable impact of complications in general surgery: a prospective cohort study.

Authors:  Eelke Bosma; Eelco J Veen; Mariska A C de Jongh; Jan A Roukema
Journal:  Can J Surg       Date:  2012-06       Impact factor: 2.089

4.  Fast-track for the modern colorectal department.

Authors:  Rishabh Sehgal; Arnold Hill; Joseph Deasy; Deborah A McNamara; Ronan A Cahill
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

5.  Redefining mortality after pancreatic cancer resection.

Authors:  James Edward Carroll; Jillian K Smith; Jessica P Simons; Melissa M Murphy; Sing Chau Ng; Shimul A Shah; Zheng Zhou; Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2010-09-16       Impact factor: 3.452

6.  Comparing complications of esophagectomy and pancreaticoduodenectomy and potential impact on hospital systems utilizing the accordion severity grading system.

Authors:  Donald E Low; Madhankumar Kuppusamy; Yasushi Hashimoto; L William Traverso
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

7.  Specific Medicare Severity-Diagnosis Related Group Codes Increase the Predictability of 30-Day Unplanned Hospital Readmission After Pancreaticoduodenectomy.

Authors:  Dimitrios Xourafas; Katiuscha Merath; Gaya Spolverato; Stanley W Ashley; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

Review 8.  Optimising organ perfusion in the high-risk surgical and critical care patient: a narrative review.

Authors:  Thomas Parker; David Brealey; Alex Dyson; Mervyn Singer
Journal:  Br J Anaesth       Date:  2019-05-02       Impact factor: 9.166

9.  Age and preexisting conditions as risk factors for severe adverse events and failure to rescue after injury.

Authors:  Emily Earl-Royal; Elinore J Kaufman; Jesse Y Hsu; Douglas J Wiebe; Patrick M Reilly; Daniel N Holena
Journal:  J Surg Res       Date:  2016-07-05       Impact factor: 2.192

Review 10.  Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States.

Authors:  Ashley L Cole; Anna E Austin; Ryan P Hickson; Matthew S Dixon; Emma L Barber
Journal:  Cancer Epidemiol       Date:  2018-05-25       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.